As managing the side effects of chemotherapy becomes a priority in the field of oncology, research into treatments such as scalp cooling and cryocompression for chemotherapy-induced peripheral neuropathy has become essential.
In this section, you will find a variety of articles exploring the latest advancements and notable research on the use of cryogenic caps.
These studies and publications provide detailed and up-to-date information on the effectiveness, applications, and benefits of this innovative technique to mitigate hair loss and other side effects during chemotherapy treatment.
Estimated Hair Loss Without Scalp Cooling (No Cap):
That is, out of every 100 patients undergoing this type of chemotherapy, approximately XX% experience significant hair loss.
Estimated Hair Loss with Scalp Cooling (With Cap):
That is, out of every 100 patients using scalp cooling, hair is preserved in an impressive XX% of cases.
This data has been analyzed and compiled from several dozen scientific studies and articles published in prestigious journals. Using cutting-edge artificial intelligence, the results have been processed and combined to provide a precise and up-to-date view of the probability of hair loss during chemotherapy treatments.
The use of cooling caps may not be suitable for certain types of cancer or chemotherapy treatments, such as leukemia and lymphoma. For patients with metastases in the scalp or any area of the head (including the skull and meninges), the decision to use cooling should be assessed on an individual basis and always under the supervision of a specialized medical team.
Here you will find published scientific studies, carefully analyzed, translated, and interpreted using artificial intelligence to facilitate understanding and application in managing the side effects of chemotherapy.
The United States Food and Drug Administration (FDA) has approved the expanded use of a cooling system, known as a
Introduction Chemotherapy-induced alopecia (CIA) is a common and emotionally distressing side effect for patients with early-stage breast cancer. Scalp cooling
Introduction This article addresses one of the most distressing side effects of chemotherapy: induced alopecia. Hair loss has a considerable
Introduction Scalp cooling has been used since the 1970s to mitigate chemotherapy-induced alopecia (CIA), a common and emotionally challenging side
Introduction: The gel-based scalp cooling cap is a tool used to prevent hair loss in patients undergoing chemotherapy. This device
Document Analysis Method: In today’s digital age, artificial intelligence (AI) has transformed how we process and understand information. Using advanced
Scalp cooling caps are an effective tool to reduce hair loss during chemotherapy treatments. Below is a detailed guide on
A Breakthrough in Patient Care: The Scalp Cooling Cap Patent Short Description The 1980 scalp cooling cap patent introduced an
Introduction Scalp cooling has been used to mitigate chemotherapy-induced alopecia (CIA), but few studies have been conducted on Asian patients.
Introduction: Scalp cooling is the only available method to prevent chemotherapy-induced alopecia (CIA). Although its effectiveness varies, being satisfactory in
Scalp cooling caps have become a useful tool for reducing hair loss during chemotherapy. However, there are specific situations where
Introduction Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of breast cancer treatment. Hair loss,
Introduction Chemotherapy-induced alopecia (CIA) is a side effect that can have a significant emotional impact on cancer patients. Although generally
Introduction The study “Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Receiving Chemotherapy: A Prospective Multicenter Study of
Choosing a scalp cooling cap during chemotherapy is a decision that impacts the physical and emotional well-being of those going
A cooling cap is a specially designed device placed on the scalp to keep it cool during chemotherapy. The cooling
Hair loss is one of the most visible and emotional side effects of chemotherapy, profoundly impacting the self-esteem and emotional
The Princess of Wales, Kate Middleton, visited the Royal Marsden Hospital in London, where she received oncology treatment in 2024.
consultas@criobella.com